Nov 23 2013
The spin-off from Joseph Fourier University, Grenoble (UJF), starts its incubation period accompanied by Grenoble’s innovation accelerators, Gravit and GATE1. Based on research by its leader, Prof. Jean Viallet (Associate Professor at UJF), the team intends to develop very promising in vivo assays for drug development, particularly for cancer treatments
Nov 28-30
2023
Come and join us at NLS DAYS, Nov 28-30 2023 in Copenhagen, Sweden
Join INOVOTION at the NLS Days’ 10th anniversary in Copenhagen. This is the premier Nordic event for partnering in Life Sciences. Come and meet INOVOTION on the MabDesign/Choose France stand (A37-38-39-40-41). This is huge opportunity to learn […]
Nov 22
2023
ORGA-SOFT-OVO project formally accepted for funding
INOVOTION and its partners Cell&Soft, Hospices Civils de Lyon – HCL, and CRCL Centre de Recherche en Cancérologie de Lyon proudly announce that its ambitious ORGA-SOFT-OVO project has been formally accepted for funding. This is […]
Nov 6-8
2023
Come and join us at BIO-EUROPE, Nov 6-8 2023 in Munich, Germany
Join INOVOTION at this exciting event, to learn about our unique model for in vivo cancer drug evaluation. Connect with the right partners at Europe’s largest partnering event. Sales Director Arnaud Peyronnier and CEO/CSO Jean Viallet will […]
